Citation

Alka Khaitan, Jane C. Lindsey, Edmund Capparelli, Camlin Tierney, Anne Coletti, Charlotte Perlowski, Dwight E. Yin, Mary Elizabeth (Betsy) Smith, Hans M.L. Spiegel, Sai Majji, Jack Moye, Lucio Gama, Lynette Purdue, Chelsea Krotje, Paul Harding, Mark Cotton, Diane Costello, Christos J Petropoulos, Jacqueline D Reeves, Macpherson Mallewa, Rachel Chihana , Portia Kamthunzi, Tapiwa G. Mbengeranwa, Gaerolwe Masheto, Maria Letícia Santos Cruz, Jose Henrique Pilotto, Ponego L. Ponatshego, Deborah Persaud, Elizabeth J. McFarland, IMPAACT 2008 Team, Richard A Koup, Bob C Lin, Adrian B McDermott. VRC01 with antiretroviral initiation in infants is well tolerated, and higher concentrations associate with greater HIV-1 DNA declines. Science Translational Medicine. 2026 May 26; 18(848). doi: 10.1126/scitranslmed.adr4509. PMID: 42090482; PMCID: PMC13541427.

Citation

Christiana Smith, Emily Anne Barr, Karen Hampanda, Mark Trumbull, Hulin Wu, Jennifer McKinney, Sarah Buisson, Carly Hoffmann, Ciarra Covin, Angela Hutchinson, K. Rivet Amico, Ifeyinwa V. Asiodu, Elizabeth J. McFarland, Margaret Lampe, Preetam A. Cholli, Olga Varechtchouk, Allahna Esber, Athena P. Kourtis, Lisa Abuogi, UPLIFT (IMPAACT 2046) study team. Understanding practices of lactation and infant feeding together with women with HIV: the UPLIFT observational study protocol. Frontiers in Reproductive Health. 2026 Jul 07; 8. doi: 10.3389/frph.2026.1856899. PMID: 42488399; PMCID: PMC13388547.

Citation

David Nerguizian, Brandon Klein, Farah Abdelmawla, Joe Gomez , Peter L Anderson, Lane Bushman, Kristina M Brooks. Validation of an UHPLC-MS/MS Assay for the Quantification of Isoniazid and Four Major Metabolites in Human Plasma. Biomedical Chromatography. 2026 Jul 17; PMID: 42466481; PMCID: PMC13377673.

Citation

Benjamin H Chi, Deborah Kacanek, Emily Brown, K Rivet Amico, Sharon Huang, Teacler Nematadzira, Elizea Horne, Clemensia Nakabiito, Sharon K Mambiya, Violet Korutaro, Tichaona Vhembo, Michael Whitton, Benjamin Johnston, Olga Varechtchouk, Hans Spiegel, Peter L Anderson, Lynda Stranix-Chibanda , IMPAACT 2009 protocol team. Maternal and pregnancy outcomes in women offered daily oral preexposure prophylaxis during pregnancy and postpartum. Journal of International AIDS Society. 2026 Jul 28; doi: 10.1097/QAD.0000000000004588. PMID: 42517223; PMCID: PMC13431001.

Citation

Emily Anne Barr, Mauricio Pinilla, Jeremiah D Momper, Ahizechukwu C Eke, Lucy Koech, Kristina M Brooks, Victoria Ndyanabangi, Sandra Burchette, Sujith Valiyaparambil, Mark Mirochnik, Alice Stek, Brookie Best, Rachael Jeffrey, Chelsea Krotje, Marije Van Schalkwyk, Renee Browning, David Shapiro, Kathleen M Powis. Breastmilk transfer and infant exposure to atazanavir/ritonavir in breastfeeding women with HIV: results from IMPAACT 2026. Frontiers in Reproductive Health. 2026 Aug 21; doi: doi: 10.3389/frph.2026.1892081. eCollection 2026. PMID: 42666560; PMCID: PMC13523135.

Citation

Patience Atuhaire, Mark J Giganti, Flynn McMorrow, Maxensia Owor, Philippa Musoke, Mary Glenn Fowler, Promise Bf Team. Congenital Infections as Risk Factor For Adverse Birth Outcomes Among HIV-Exposed Neonates in Uganda. Journal of the Pediatric Infectious Diseases Society. 2026 Sep 10; doi: 10.1093/jpids/piag090. PMID: 42720400; PMCID: 13641073.

Citation

Isabelle Roseto, Lori Silveira, Kaili Curtis, Jennifer Canniff, Adriana Weinberg, Christiana Smith. Characterizing immune activation in HIV-exposed but uninfected infants in the first year of life. Frontiers in Immunology. 2026 Sep 03; 17:1914801. doi: DOI: 10.3389/fimmu.2026.1914801. PMID: 42755921; PMCID: PMC13582223.

Citation

Ravi Jhaveri, Kristina M. Brooks, Vincent Mainella, John Marcinak, Mong-Jen Chen, Katie McCarthy, Camlin Tierney, Zhongli J. Zhang, Bryan Nelson, Pat Flynn, Nathan Furukawa, Ahizechukwu C. Eke, IMPAACT 2041 Protocol Team. IMPAACT 2041: Designing the Study of Glecaprevir/Pibrentasvir Treatment During Pregnancy. Open Forum Infectious Diseases. 2026 Aug 28; 13(9). doi: 10.1093/ofid/ofag537. PMID: 42703521; PMCID: PMC13546789.

Citation

Marije Van Schalkwyk, Jiajia Wang, Adrie Bekker, Eric Decloedt, Gerhard B Theron , Mark F Cotton, Tim R Cressey, Deo Wabwire, Chelsea Stotz, Kevin Knowles, Kathleen George, Renee Browning, Kittipong Rungruengthanakit, Lubbe Wiesner, Edmund V Capparelli, Alice M Stek, Mark Mirochnick, David E Shapiro, Brookie M Best, Ahizechukwu C Eke, IMPAACT P1026s Protocol Team. Pharmacokinetics of Efavirenz in Pregnancy and Postpartum with and without First-line Tuberculosis Drugs: Results from IMPAACT P1026s. Clinical Pharmacokinetics. 2026 Oct 03; doi: doi: 10.1007/s40262-026-01690-w. PMID: 42828638.

Citation

Carolyn Bolton Moore, Kristin Baltrusaitis, Edmund V Capparelli, Elizabeth D Lowenthal, Dwight E Yin, John H Moye , Christiana Smith, Michael Whitton, Conn M Harrington , Herta Crauwels, Rodica Van Solingen-Ristea, Mark A Marzinke, Barbara Heckman, Andi Ace, Shawn Ward, Kyle Whitson, Jenny Huang, S Y Amy Cheung, Brookie M Best, Ellen Townley, Allison Agwu, Pradthana Ounchanum, Sisinyana Ruth Mathiba, Linda Aurpibul, Violet Korutaro, Gaerolwe Masheto, Faeezah Patel, Evette Moodley, Aditya H Gaur, IMPAACT 2017 Collaborators for the IMPAACT 2017 Team. Safety, antiviral activity, and pharmacokinetics of long-acting cabotegravir plus long-acting rilpivirine in virologically suppressed adolescents living with HIV-1 (IMPAACT 2017/MOCHA): week 96 and end-of-study results from a multinational, phase 1/2, single-arm trial. Lancet Child and Adolescent Health. 2026 Oct 06; S2352-4642. doi: 10.1016/S2352-4642(26)00221-X. PMID: 42838065.